Home › Research › Treatments
Comparative safety of cholinesterase inhibitors and memantine for dementia: a protocol for a network meta-analysis of randomized controlled trials
Moaz Elsayed Abouelmagd, Nereen A Almosilhy, Hamdy A Makhlouf, Amr K Hassan, Ahmed S A Osman, Mahmoud Diaa Hindawi, Ahmed Elshahat, Asmaa Zakria Alnajjar et al.. Systematic reviews, 2025-11-04
Topic: Drug trials: efficacy and safety
Plain-language summary
By addressing gaps in prior NMAs, this study aims to provide an in-depth evaluation of safety outcomes associated with different ChEI and memantine doses and formulations across various dementia types. The findings will support clinicians in making informed treatment decisions and guide future research and policy development for dementia management. SYSTEMATIC REVIEW REGISTRATION: PROSPERO (CRD42025642902).
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Abouelmagd, M. E., Almosilhy, N. A., Makhlouf, H. A., Hassan, A. K., Osman, A. S. A., Hindawi, M. D., et al. (2025). Comparative safety of cholinesterase inhibitors and memantine for dementia: a protocol for a network meta-analysis of randomized controlled trials. Systematic reviews. https://doi.org/10.1186/s13643-025-02961-6
Vancouver
Abouelmagd ME, Almosilhy NA, Makhlouf HA, Hassan AK, Osman ASA, Hindawi MD, et al. Comparative safety of cholinesterase inhibitors and memantine for dementia: a protocol for a network meta-analysis of randomized controlled trials. Systematic reviews. 2025. doi:10.1186/s13643-025-02961-6. PMID: 41188985.
BibTeX
@article{abouelmagd2025-41188985,
author = {Abouelmagd, Moaz Elsayed and Almosilhy, Nereen A and Makhlouf, Hamdy A and Hassan, Amr K and Osman, Ahmed S A and Hindawi, Mahmoud Diaa and Elshahat, Ahmed and Alnajjar, Asmaa Zakria and others},
title = {{Comparative safety of cholinesterase inhibitors and memantine for dementia: a protocol for a network meta-analysis of randomized controlled trials}},
journal = {Systematic reviews},
year = {2025},
doi = {10.1186/s13643-025-02961-6},
pmid = {41188985},
url = {https://doi.org/10.1186/s13643-025-02961-6}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- By addressing gaps in prior NMAs, this study aims to provide an in-depth evaluation of safety outcomes associated with different ChEI and memantine doses and formulations across various dementia types.
- The findings will support clinicians in making informed treatment decisions and guide future research and policy development for dementia management.
- SYSTEMATIC REVIEW REGISTRATION: PROSPERO (CRD42025642902).
New to this subject? Start with our plain-English guide: Treatments →
Study details
- Study designsystematic review
- Evidence strengthHigh
How this study scored 71/100
Published in a peer-reviewed journal, and it is a systematic review of all the studies on the question. Scored zero for sample size, effect reported and studied in people because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record, multicenter collaboration and free to read, so those were left out: it earned 40 of the 56 points we could judge it on, which is 71 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Systematic reviews) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 12 / 12 | A systematic review of all the studies on the question |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41188985) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 40 / 56 | Scored on 10 of 20 parts. We have no data for the rest, so they are left out: 40 of the 56 points we could judge it on is 71 out of 100. |
| Total | 71 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Treatments from nearby years
Also tagged “cholinesterase”
271 studies in the library carry the topic tag “cholinesterase”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 271 tagged studies.